GlaxoSmithKline_NNP 153_CD Shareholder_NN information_NN Ordinary_NNP shares_NNS Annual_JJ General_NNP Meeting_VBG 2003_CD The_DT company_NN 's_POS shares_NNS are_VBP listed_VBN on_IN the_DT London_NNP Stock_NNP Exchange_NNP ._.
The_DT Queen_NNP Elizabeth_NNP II_NNP Conference_NNP Centre_NNP ,_, 19th_JJ May_NNP 2003_CD Broad_NNP Sanctuary_NNP ,_, Westminster_NNP ,_, Registrar_NNP London_NNP SW1P_NNP 3EE_NNP The_DT company_NN 's_POS share_NN register_NN is_VBZ administered_VBN by_IN Lloyds_NNP TSB_NNP Registrars_NNPS ,_, who_WP also_RB provide_VBP the_DT following_JJ services_NNS :_: The_DT Annual_JJ General_NNP Meeting_VBG is_VBZ the_DT company_NN 's_POS principal_JJ forum_NN for_IN communication_NN with_IN private_JJ shareholders_NNS ._.
In_IN addition_NN to_TO the_DT formal_JJ GlaxoSmithKline_NNP Investment_NNP Plan_NNP resolutions_NNS to_TO be_VB put_VBN to_TO the_DT meeting_NN ,_, there_EX will_MD be_VB a_DT presentation_NN The_DT plan_NN enables_VBZ shareholders_NNS to_TO reinvest_VB quarterly_JJ dividends_NNS by_IN the_DT Chief_NNP Executive_NNP Officer_NNP on_IN the_DT performance_NN of_IN the_DT business_NN and_CC or_CC make_VB monthly_JJ investments_NNS in_IN the_DT company_NN 's_POS ordinary_JJ and_CC its_PRP$ future_JJ development_NN ._.
There_EX will_MD be_VB opportunity_NN for_IN questions_NNS shares_NNS using_VBG a_DT special_JJ dealing_NN arrangement_NN ._.
to_TO the_DT Board_NNP ,_, and_CC the_DT Chairmen_NNPS of_IN the_DT Board_NNP 's_POS committees_NNS will_MD GlaxoSmithKline_NNP Individual_NNP Savings_NNPS Account_NNP take_VB questions_NNS on_IN matters_NNS relating_VBG to_TO those_DT committees_NNS ._.
The_DT GlaxoSmithKline_NNP Individual_NNP Savings_NNP Account_NNP ISA_NNP is_VBZ a_DT Investors_NNS holding_VBG shares_NNS in_IN the_DT company_NN through_IN a_DT nominee_NN service_NN tax-efficient_JJ way_NN to_TO invest_VB in_IN the_DT company_NN 's_POS ordinary_JJ shares_NNS ._.
should_MD arrange_VB with_IN that_DT nominee_NN service_NN to_TO be_VB appointed_VBN as_IN a_DT GlaxoSmithKline_NNP Corporate_NNP Sponsored_NNP Nominee_NNP corporate_JJ representative_NN or_CC proxy_NN in_IN respect_NN of_IN their_PRP$ shareholding_NN The_DT corporate_JJ sponsored_VBN nominee_NN provides_VBZ a_DT facility_NN for_IN in_IN order_NN to_TO attend_VB and_CC vote_VB at_IN the_DT meeting_NN ._.
shareholders_NNS to_TO hold_VB shares_NNS without_IN the_DT need_NN for_IN share_NN ADR_NNP holders_NNS wishing_VBG to_TO attend_VB the_DT meeting_NN must_MD obtain_VB a_DT proxy_NN certificates_NNS ._.
Shareholders_NNS '_POS details_NNS will_MD not_RB be_VB held_VBN on_IN the_DT main_JJ from_IN The_DT Bank_NNP of_IN New_NNP York_NNP which_WDT will_MD enable_VB them_PRP to_TO attend_VB the_DT share_NN register_NN ,_, and_CC so_RB will_MD remain_VB confidential_JJ ._.
meeting_NN and_CC vote_NN on_IN the_DT business_NN to_TO be_VB transacted_VBN ._.
ADR_NNP holders_NNS Shareview_NNP service_NN may_MD instruct_VB The_DT Bank_NNP of_IN New_NNP York_NNP as_IN to_TO how_WRB the_DT shares_NNS The_DT shareview_NN portfolio_NN service_NN provides_VBZ shareholders_NNS with_IN represented_VBN by_IN their_PRP$ ADRs_NNS should_MD be_VB voted_VBN by_IN completing_VBG and_CC information_NN on_IN their_PRP$ investment_NN in_IN the_DT company_NN ._.
Shareholders_NNS returning_VBG the_DT voting_NN card_NN provided_VBN by_IN The_DT Bank_NNP of_IN New_NNP York_NNP in_IN may_MD register_VB for_IN this_DT service_NN at_IN www_NN ._.
accordance_NN with_IN the_DT instructions_NNS given_VBN ._.
Share_NN dealing_VBG facility_NN Financial_NNP reporting_VBG NatWest_NNP Stockbrokers_NNS Limited_JJ offers_VBZ a_DT share-dealing_JJ service_NN on_IN Financial_NNP reporting_VBG calendar_NN 2003_CD behalf_NN of_IN the_DT company_NN to_TO shareholders_NNS wishing_VBG to_TO buy_VB or_CC sell_VB the_DT Announcement_NN of_IN 1st_CD Quarter_NN Results_NNS 30th_JJ April_NNP 2003_CD company_NN 's_POS shares_NNS ._.
Announcement_NN of_IN 2nd_CD Quarter_NN Results_NNS 23rd_JJ July_NNP 2003_CD Share_NN price_NN information_NN Announcement_NN of_IN 3rd_CD Quarter_NN Results_NNS 22nd_JJ October_NNP 2003_CD Share_NN price_NN information_NN is_VBZ available_JJ on_IN the_DT company_NN 's_POS website_NN at_IN Preliminary_JJ Announcement_NN of_IN Annual_JJ Results_NNS 12th_JJ February_NNP 2004_CD www_NN ._.
Information_NN is_VBZ also_RB available_JJ on_IN Ceefax_NNP ,_, Teletext_NNP ,_, Publication_NNP of_IN Annual_JJ Report_NNP Review_NNP March_NNP 2004_CD and_CC from_IN FT_NNP Cityline_NNP by_IN calling_VBG 0906 003 5694_CD or_CC 0906 843 5694_CD calls_NNS charged_VBN at_IN 60p_CD a_DT minute_NN plus_CC VAT_NNP at_IN all_DT times_NNS ._.
Results_NNS Announcements_NNS The_DT Results_NNS Announcements_NNS are_VBP issued_VBN to_TO the_DT London_NNP Stock_NNP American_NNP Depositary_NNP Shares_NNP Exchange_NNP LSE_NNP ,_, and_CC made_VBD available_JJ on_IN the_DT LSE_NNP news_NN service_NN ,_, and_CC The_DT company_NN 's_POS shares_NNS are_VBP listed_VBN on_IN the_DT New_NNP York_NNP Stock_NNP Exchange_NNP at_IN the_DT same_JJ time_NN ,_, or_CC shortly_RB afterwards_RB ,_, are_VBP issued_VBN to_TO the_DT media_NNS ,_, in_IN the_DT form_NN of_IN American_JJ Depositary_NNP Shares_NNP ADSs_NNP and_CC these_DT are_VBP are_VBP made_VBN available_JJ on_IN the_DT website_NN and_CC are_VBP filed_VBN in_IN the_DT USA_NNP with_IN evidenced_VBN by_IN American_JJ Depositary_NNP Receipts_NNPS ADRs_NNPS ,_, each_DT one_CD of_IN the_DT Securities_NNPS and_CC Exchange_NNP Commission_NNP and_CC the_DT New_NNP York_NNP Stock_NNP which_WDT represents_VBZ two_CD ordinary_JJ shares_NNS ._.
ADR_NNP program_NN administrator_NN Financial_NNP reports_VBZ The_DT ADR_NNP program_NN is_VBZ administered_VBN by_IN The_DT Bank_NNP of_IN New_NNP York_NNP ,_, The_DT company_NN publishes_VBZ an_DT Annual_JJ Report_NNP and_CC ,_, for_IN the_DT investor_NN not_RB who_WP also_RB provide_VBP the_DT following_VBG service_NN :_: needing_VBG the_DT full_JJ detail_NN of_IN the_DT Report_NNP ,_, an_DT Annual_JJ Review_NNP ._.
These_DT are_VBP Global_JJ BuyDIRECT_NNP available_JJ from_IN the_DT date_NN of_IN publication_NN on_IN the_DT GlaxoSmithKline_NNP Global_NNP BuyDIRECT_NNP is_VBZ a_DT direct_JJ ADS_NNPS purchase_NN sale_NN and_CC dividend_NN website_NN ._.
reinvestment_NN plan_NN for_IN ADR_NNP holders_NNS ._.
The_DT Annual_JJ Review_NNP is_VBZ sent_VBN to_TO all_DT shareholders_NNS on_IN the_DT date_NN of_IN publication_NN ._.
Shareholders_NNS may_MD elect_VB to_TO receive_VB also_RB the_DT Report_NNP by_IN Publications_NNP writing_VBG to_TO the_DT companys_NNS registrars_NNS ._.
Alternatively_RB shareholders_NNS may_MD elect_VB to_TO receive_VB notification_NN by_IN email_NN of_IN the_DT publication_NN of_IN financial_JJ This_DT year_NN GlaxoSmithKline_NNP has_VBZ again_RB produced_VBN a_DT separate_JJ report_NN reports_NNS by_IN registering_VBG on_IN www_NN ._.
covering_VBG the_DT Groups_NNS contribution_NN to_TO society_NN ._.
The_DT 2002_CD Corporate_JJ and_CC Social_NNP Responsibility_NNP Report_NNP covers_VBZ the_DT issues_NNS that_WDT are_VBP of_IN Copies_NNS of_IN previous_JJ financial_JJ reports_NNS are_VBP available_JJ on_IN the_DT company_NN 's_POS primary_JJ interest_NN to_TO stakeholders_NNS ,_, including_VBG the_DT contribution_NN to_TO website_VB ._.
Printed_NNP copies_NNS can_MD be_VB obtained_VBN from_IN the_DT registrar_NN in_IN the_DT society_NN ,_, business_NN ethics_NNS and_CC integrity_NN ,_, access_NN to_TO medicines_NNS ,_, R&D_NNP ,_, UK_NNP and_CC from_IN the_DT Customer_NN Response_NNP Center_NNP in_IN the_DT USA_NNP ._.
community_NN investment_NN ,_, the_DT environment_NN and_CC health_NN and_CC safety_NN ._.
The_DT report_NN is_VBZ available_JJ from_IN the_DT Secretariat_NNP at_IN the_DT companys_NNS head_VBP office_NN and_CC the_DT website_NN at_IN www_NN ._.
